Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia.

Paris J, Morgan M, Campos J, Spencer GJ, Shmakova A, Ivanova I, Mapperley C, Lawson H, Wotherspoon DA, Sepulveda C, Vukovic M, Allen L, Sarapuu A, Tavosanis A, Guitart AV, Villacreces A, Much C, Choe J, Azar A, van de Lagemaat LN, Vernimmen D, Nehme A, Mazurier F, Somervaille TCP, Gregory RI, O'Carroll D, Kranc KR.

Cell Stem Cell. 2019 Jul 3;25(1):137-148.e6. doi: 10.1016/j.stem.2019.03.021. Epub 2019 Apr 25.

2.

Expression Profiling of Calcium Channels and Calcium-Activated Potassium Channels in Colorectal Cancer.

Ibrahim S, Dakik H, Vandier C, Chautard R, Paintaud G, Mazurier F, Lecomte T, Guéguinou M, Raoul W.

Cancers (Basel). 2019 Apr 19;11(4). pii: E561. doi: 10.3390/cancers11040561.

3.

A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome.

Voeltzel T, Flores-Violante M, Zylbersztejn F, Lefort S, Billandon M, Jeanpierre S, Joly S, Fossard G, Milenkov M, Mazurier F, Nehme A, Belhabri A, Paubelle E, Thomas X, Michallet M, Louache F, Nicolini FE, Caron de Fromentel C, Maguer-Satta V.

Cell Death Dis. 2018 Sep 27;9(10):1011. doi: 10.1038/s41419-018-1042-7.

4.

Signaling pathways activated by PACAP in MCF-7 breast cancer cells.

Zibara K, Zeidan A, Mallah K, Kassem N, Awad A, Mazurier F, Badran B, El-Zein N.

Cell Signal. 2018 Oct;50:37-47. doi: 10.1016/j.cellsig.2018.06.009. Epub 2018 Jun 20.

PMID:
29935235
5.

Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.

Cheloni G, Tanturli M, Tusa I, Ho DeSouza N, Shan Y, Gozzini A, Mazurier F, Rovida E, Li S, Dello Sbarba P.

Blood. 2017 Aug 3;130(5):655-665. doi: 10.1182/blood-2016-10-745588. Epub 2017 Jun 2.

6.

Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma.

Nguyen PH, Giraud J, Chambonnier L, Dubus P, Wittkop L, Belleannée G, Collet D, Soubeyran I, Evrard S, Rousseau B, Senant-Dugot N, Mégraud F, Mazurier F, Varon C.

Clin Cancer Res. 2017 Mar 15;23(6):1586-1597. doi: 10.1158/1078-0432.CCR-15-2157. Epub 2016 Sep 12.

7.

Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses.

Bourgeais J, Ishac N, Medrzycki M, Brachet-Botineau M, Desbourdes L, Gouilleux-Gruart V, Pecnard E, Rouleux-Bonnin F, Gyan E, Domenech J, Mazurier F, Moriggl R, Bunting KD, Herault O, Gouilleux F.

Oncotarget. 2017 Jun 27;8(26):41876-41889. doi: 10.18632/oncotarget.11480.

8.

Hypoxia and Hypoxia-Inducible Factors in Leukemias.

Deynoux M, Sunter N, Hérault O, Mazurier F.

Front Oncol. 2016 Feb 26;6:41. doi: 10.3389/fonc.2016.00041. eCollection 2016. Review.

9.

Premature skin aging features rescued by inhibition of NADPH oxidase activity in XPC-deficient mice.

Hosseini M, Mahfouf W, Serrano-Sanchez M, Raad H, Harfouche G, Bonneu M, Claverol S, Mazurier F, Rossignol R, Taieb A, Rezvani HR.

J Invest Dermatol. 2015 Apr;135(4):1108-1118. doi: 10.1038/jid.2014.511. Epub 2014 Dec 1.

10.

HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress.

Rouault-Pierre K, Lopez-Onieva L, Foster K, Anjos-Afonso F, Lamrissi-Garcia I, Serrano-Sanchez M, Mitter R, Ivanovic Z, de Verneuil H, Gribben J, Taussig D, Rezvani HR, Mazurier F, Bonnet D.

Cell Stem Cell. 2013 Nov 7;13(5):549-63. doi: 10.1016/j.stem.2013.08.011. Epub 2013 Oct 3.

11.

Loss of epidermal hypoxia-inducible factor-1α accelerates epidermal aging and affects re-epithelialization in human and mouse.

Rezvani HR, Ali N, Serrano-Sanchez M, Dubus P, Varon C, Ged C, Pain C, Cario-André M, Seneschal J, Taïeb A, de Verneuil H, Mazurier F.

J Cell Sci. 2011 Dec 15;124(Pt 24):4172-83. doi: 10.1242/jcs.082370. Epub 2011 Dec 22.

12.

Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice.

Varon C, Dubus P, Mazurier F, Asencio C, Chambonnier L, Ferrand J, Giese A, Senant-Dugot N, Carlotti M, Mégraud F.

Gastroenterology. 2012 Feb;142(2):281-91. doi: 10.1053/j.gastro.2011.10.036. Epub 2011 Nov 4.

PMID:
22062361
13.

HIF-1α in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders.

Rezvani HR, Ali N, Nissen LJ, Harfouche G, de Verneuil H, Taïeb A, Mazurier F.

J Invest Dermatol. 2011 Sep;131(9):1793-805. doi: 10.1038/jid.2011.141. Epub 2011 Jun 2. Review.

14.

Clinical-scale cultures of cord blood CD34(+) cells to amplify committed progenitors and maintain stem cell activity.

Ivanovic Z, Duchez P, Chevaleyre J, Vlaski M, Lafarge X, Dazey B, Robert-Richard E, Mazurier F, Boiron JM.

Cell Transplant. 2011;20(9):1453-63. doi: 10.3727/096368910X552853. Epub 2011 Feb 3.

PMID:
21294956
15.

XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species.

Rezvani HR, Rossignol R, Ali N, Benard G, Tang X, Yang HS, Jouary T, de Verneuil H, Taïeb A, Kim AL, Mazurier F.

Biochim Biophys Acta. 2011 Jun;1807(6):609-19. doi: 10.1016/j.bbabio.2010.12.006. Epub 2010 Dec 15.

16.

XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas.

Rezvani HR, Kim AL, Rossignol R, Ali N, Daly M, Mahfouf W, Bellance N, Taïeb A, de Verneuil H, Mazurier F, Bickers DR.

J Clin Invest. 2011 Jan;121(1):195-211. doi: 10.1172/JCI40087. Epub 2010 Dec 1.

17.

Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.

Robert-Richard E, Lalanne M, Lamrissi-Garcia I, Guyonnet-Duperat V, Richard E, Pitard V, Mazurier F, Moreau-Gaudry F, Ged C, de Verneuil H.

J Gene Med. 2010 Aug;12(8):637-46. doi: 10.1002/jgm.1478.

PMID:
20586119
18.

The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A.

Dedieu S, Canron X, Rezvani HR, Bouchecareilh M, Mazurier F, Sinisi R, Zanda M, Moenner M, Bikfalvi A, North S.

BMC Med. 2010 Mar 24;8:19. doi: 10.1186/1741-7015-8-19.

19.

Hypoxia-inducible factor-1alpha regulates the expression of nucleotide excision repair proteins in keratinocytes.

Rezvani HR, Mahfouf W, Ali N, Chemin C, Ged C, Kim AL, de Verneuil H, Taïeb A, Bickers DR, Mazurier F.

Nucleic Acids Res. 2010 Jan;38(3):797-809. doi: 10.1093/nar/gkp1072. Epub 2009 Nov 24.

20.

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity.

James C, Mazurier F, Dupont S, Chaligne R, Lamrissi-Garcia I, Tulliez M, Lippert E, Mahon FX, Pasquet JM, Etienne G, Delhommeau F, Giraudier S, Vainchenker W, de Verneuil H.

Blood. 2008 Sep 15;112(6):2429-38. doi: 10.1182/blood-2008-02-137877. Epub 2008 Jul 8.

21.

[Successful gene therapy of mice with congenital erythropoietic porphyria].

de Verneuil H, Robert-Richard E, Ged C, Mazurier F, Richard E, Moreau-Gaudry F.

Med Sci (Paris). 2008 Jun-Jul;24(6-7):615-20. doi: 10.1051/medsci/20082467615. French.

22.

Quantitative and qualitative in vitro analysis of the stem cell potential of hematopoietic cells purified from murine skeletal muscle.

Haond C, Farace F, Guillier M, Lécluse Y, Mazurier F, Vainchenker W, Turhan AG.

Cell Res. 2007 Sep;17(9):783-91.

23.

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis.

Chaligné R, James C, Tonetti C, Besancenot R, Le Couédic JP, Fava F, Mazurier F, Godin I, Maloum K, Larbret F, Lécluse Y, Vainchenker W, Giraudier S.

Blood. 2007 Nov 15;110(10):3735-43. Epub 2007 Aug 20.

24.

Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure.

Rezvani HR, Dedieu S, North S, Belloc F, Rossignol R, Letellier T, de Verneuil H, Taïeb A, Mazurier F.

J Biol Chem. 2007 Jun 1;282(22):16413-22. Epub 2007 Mar 30.

25.

Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.

Boiron JM, Dazey B, Cailliot C, Launay B, Attal M, Mazurier F, McNiece IK, Ivanovic Z, Caraux J, Marit G, Reiffers J.

Transfusion. 2006 Nov;46(11):1934-42.

PMID:
17076849
26.

Human cell engraftment after busulfan or irradiation conditioning of NOD/SCID mice.

Robert-Richard E, Ged C, Ortet J, Santarelli X, Lamrissi-Garcia I, de Verneuil H, Mazurier F.

Haematologica. 2006 Oct;91(10):1384.

27.

Protective effects of catalase overexpression on UVB-induced apoptosis in normal human keratinocytes.

Rezvani HR, Mazurier F, Cario-André M, Pain C, Ged C, Taïeb A, de Verneuil H.

J Biol Chem. 2006 Jun 30;281(26):17999-8007. Epub 2006 Apr 27.

28.

A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium.

Ivanovic Z, Duchez P, Dazey B, Hermitte F, Lamrissi-Garcia I, Mazurier F, Praloran V, Reiffers J, Vezon G, Boiron JM.

Transfusion. 2006 Jan;46(1):126-31.

PMID:
16398741
29.

A knock-in mouse model of congenital erythropoietic porphyria.

Ged C, Mendez M, Robert E, Lalanne M, Lamrissi-Garcia I, Costet P, Daniel JY, Dubus P, Mazurier F, Moreau-Gaudry F, de Verneuil H.

Genomics. 2006 Jan;87(1):84-92. Epub 2005 Nov 28.

30.

Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion.

Madlambayan GJ, Rogers I, Kirouac DC, Yamanaka N, Mazurier F, Doedens M, Casper RF, Dick JE, Zandstra PW.

Exp Hematol. 2005 Oct;33(10):1229-39. Erratum in: Exp Hematol. 2006 Jan;34(1):122.

PMID:
16219546
31.

SCL/TAL1 expression level regulates human hematopoietic stem cell self-renewal and engraftment.

Reynaud D, Ravet E, Titeux M, Mazurier F, Rénia L, Dubart-Kupperschmitt A, Roméo PH, Pflumio F.

Blood. 2005 Oct 1;106(7):2318-28. Epub 2005 Jun 16.

32.

Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression.

Wang L, Menendez P, Shojaei F, Li L, Mazurier F, Dick JE, Cerdan C, Levac K, Bhatia M.

J Exp Med. 2005 May 16;201(10):1603-14. Epub 2005 May 9.

33.
34.

Characterization of cord blood hematopoietic stem cells.

Mazurier F, Doedens M, Gan OI, Dick JE.

Ann N Y Acad Sci. 2003 May;996:67-71.

PMID:
12799284
35.
36.

Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection.

Richard E, Mendez M, Mazurier F, Morel C, Costet P, Xia P, Fontanellas A, Geronimi F, Cario-André M, Taine L, Ged C, Malik P, de Verneuil H, Moreau-Gaudry F.

Mol Ther. 2001 Oct;4(4):331-8.

37.

Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells.

Fontanellas A, Mendez M, Mazurier F, Cario-André M, Navarro S, Ged C, Taine L, Géronimi F, Richard E, Moreau-Gaudry F, Enriquez De Salamanca R, de Verneuil H.

Gene Ther. 2001 Apr;8(8):618-26.

38.

Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.

Mazurier F, Géronimi F, Lamrissi-Garcia I, Morel C, Richard E, Ged C, Fontanellas A, Moreau-Gaudry F, Morey M, de Verneuil H.

Mol Ther. 2001 Mar;3(3):411-7.

39.

Reversion of hepatobiliary alterations By bone marrow transplantation in a murine model of erythropoietic protoporphyria.

Fontanellas A, Mazurier F, Landry M, Taine L, Morel C, Larou M, Daniel JY, Montagutelli X, de Salamanca RE, de Verneuil H.

Hepatology. 2000 Jul;32(1):73-81.

PMID:
10869291
40.

Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter.

Vekris A, Maurange C, Moonen C, Mazurier F, De Verneuil H, Canioni P, Voisin P.

J Gene Med. 2000 Mar-Apr;2(2):89-96.

PMID:
10809142
41.

Fluorescence-based selection of retrovirally transduced cells in congenital erythropoietic porphyria: direct selection based on the expression of the therapeutic gene.

Fontanellas A, Mazurier F, Belloc F, Taine L, Dumain P, Morel C, Ged C, de Verneuil H, Moreau-Gaudry F.

J Gene Med. 1999 Sep-Oct;1(5):322-30.

PMID:
10738549
43.

A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment.

Mazurier F, Fontanellas A, Salesse S, Taine L, Landriau S, Moreau-Gaudry F, Reiffers J, Peault B, Di Santo JP, de Verneuil H.

J Interferon Cytokine Res. 1999 May;19(5):533-41.

PMID:
10386866
44.

[Prospects for gene therapy in hematology].

Moreau-Gaudry F, Mazurier F, Salesse S, Fontanellas A, Verneuil HD.

Ann Biol Clin (Paris). 1999 Jan-Feb;57(1):43-50. Review. French.

45.

Retroviral vector-mediated transfer of the interferon-alpha gene in chronic myeloid leukemia cells.

Salesse S, Moreau-Gaudry F, Pigeonnier-Lagarde V, Mazurier F, Chahine H, Ged C, de Verneuil H, Reiffers J, Mahon FX.

Cancer Gene Ther. 1998 Nov-Dec;5(6):390-400.

PMID:
9917094
46.

Rapid analysis and efficient selection of human transduced primitive hematopoietic cells using the humanized S65T green fluorescent protein.

Mazurier F, Moreau-Gaudry F, Maguer-Satta V, Salesse S, Pigeonnier-Lagarde V, Ged C, Belloc F, Lacombe F, Mahon FX, Reiffers J, de Verneuil H.

Gene Ther. 1998 Apr;5(4):556-62.

47.

Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria.

Mazurier F, Moreau-Gaudry F, Salesse S, Barbot C, Ged C, Reiffers J, de Verneuil H.

J Inherit Metab Dis. 1997 Jun;20(2):247-57.

PMID:
9211197
48.

Correction of the enzyme deficit of bone marrow cells in congenital erythropoietic porphyria by retroviral gene transfer.

Moreau-Gaudry F, Barbot C, Mazurier F, Mahon FX, Reiffers J, Ged C, de Verneuil H.

Hematol Cell Ther. 1996 Apr;38(2):217-20. No abstract available.

PMID:
8932010
49.
50.

Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transfer.

Moreau-Gaudry F, Ged C, Barbot C, Mazurier F, Boiron JM, Bensidhoum M, Reiffers J, de Verneuil H.

Hum Gene Ther. 1995 Jan;6(1):13-20.

PMID:
7703283

Supplemental Content

Loading ...
Support Center